Specific immunity to human papilloma virus (HPV) in patients with genital warts.
AUTOR(ES)
Viac, J
RESUMO
A study of human papilloma virus (HPV) specific cellular and humoral immunity in 30 patients with genital warts is reported. By in vivo testing with purified, inactivated plantar wart virus, a cell-mediated immunity to HPV was determined in 60% of patients. Circulating antibodies, evaluated by immunofluorescence testing, were rare, but these increased after an intradermal test had been carried out, especially in patients with a positive skin test, suggesting a booster effect. No significant difference was found between this group of patients and those having skin warts. Our results showed a specific immune response to HPV in most patients, confirming the role of the viral agent in the induction of genital warts.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045484Documentos Relacionados
- Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.
- Detection of human papilloma virus DNA in semen from patients with intrameatal penile warts.
- Demonstration of virus particles in human genital warts.
- Delayed presentation of patients with genital warts.
- Genital Warts. Human Papillomavirus Infection
